SEC Form 4 · accession 0001493152-18-001520
VBI Vaccines Inc/BC · VBIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Athena Kartsaklis
Officer — SVP Finance, CCO
Period of report
Jan 23, 2018
Accepted (ET)
Feb 6, 2018 · 1:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000764195
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy Common Shares)F1,F2,F3 | $4.255 | Jan 23, 2018 | A | 75,000 | A | — | Jan 23, 2028 | Common Shares | 75,000 | 75,000 | D |
Explanation of responses
- F1Exercise price is in Canadian dollars. United States dollars equivalent is shown using the closing foreign exchange rate on the Grant Date (as defined below).
- F2The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 23, 2018 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 23, 2018 (the "Option Agreement"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date.
- F3The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.